fda approval of tirzepatide for Weight Loss Tirzepatide for Weight Loss Receives

NICE already recommends weight loss as a core treatment for osteoarthritis, and Wegovy is the first evidence-backed pharmacological tool to support that recommendation in adults living with knee osteoarthritis and obesity

Patients using PlexusDx can request the Precision Peptide Genetic Test as an optional add-on after their first month of treatment ($99), which analyzes 14 metabolic pathways and 49 peptides to identify individual genetic factors affecting GLP-1 receptor function and weight loss response

Side Effects and Considerations Common side effects for both include: Nausea Vomiting Diarrhea Reduced appetite However, Mounjaro users may experience slightly more digestive issues, whereas Ozempic has a longer track record of safety

Yet, interest in these microdoses has accelerated, fueled by #telehealth companies and social media influencers capitalizing on wellness and biohacking trends